Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $503,423 - $579,600
6,900 New
6,900 $578,000
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $432,000 - $514,650
7,500 New
7,500 $513,000
Q3 2023

Nov 15, 2023

BUY
$50.19 - $54.68 $316,197 - $344,484
6,300 New
6,300 $332,000
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $70,480 - $94,200
2,000 Added 35.09%
7,700 $286,000
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $216,999 - $255,758
5,700 New
5,700 $239,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.